Literature DB >> 17329959

Lysophosphatidic acid inhibits serum deprivation-induced autophagy in human prostate cancer PC-3 cells.

Chi-Lun Chang1, Jia-Jun Liao, Wei-Pang Huang, Hsinyu Lee.   

Abstract

Lysophosphatidic acid (LPA) is a platelet-enriched bioactive lysophospholipid. By binding to its cognitive G protein-coupled receptors, which are encoded by endothelial differentiation genes (edgs), LPA regulates various cellular activities including proliferation, survival, and migration. Currently, little is known about the influences of LPA on autophagy, a pivotal mechanism for cell survival during conditions of starvation. Herein we present data indicating that LPA attenuates starvation-induced autophagy, by monitoring the percentage of LC3-II, an autophagy indicator, in human prostate PC-3 cells. In addition, by using cells stably expressing EGFP-LC3, LPA is shown to inhibit the formation of autophagosomes in serum-starved conditions. Our results suggest that in these conditions, LPA inhibits autophagy, which might facilitate early cancer development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17329959     DOI: 10.4161/auto.3909

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  9 in total

Review 1.  Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.

Authors:  Mu-En Lin; Deron R Herr; Jerold Chun
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-03-04       Impact factor: 3.072

2.  A method to measure cardiac autophagic flux in vivo.

Authors:  Eri Iwai-Kanai; Hua Yuan; Chengqun Huang; M Richard Sayen; Cynthia N Perry-Garza; Lucy Kim; Roberta A Gottlieb
Journal:  Autophagy       Date:  2008-01-18       Impact factor: 16.016

3.  Involvement of autophagy in ovarian cancer: a working hypothesis.

Authors:  Claudia Peracchio; Oscar Alabiso; Guido Valente; Ciro Isidoro
Journal:  J Ovarian Res       Date:  2012-09-13       Impact factor: 4.234

Review 4.  The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role.

Authors:  Chanitra Thuwajit; Alessandra Ferraresi; Rossella Titone; Peti Thuwajit; Ciro Isidoro
Journal:  Med Res Rev       Date:  2017-09-19       Impact factor: 12.944

5.  Evaluation of lysophosphatidic acid in vaginal fluid as a biomarker for ovarian cancer: A pilot study.

Authors:  Evelyn Minis; Kevin Holcomb; Giovanni Sisti; Dimitrios Nasioudis; Tomi T Kanninen; Aikaterini Athanasiou; Melissa K Frey; Eloise Chapman-Davis; Thomas A Caputo; Steven S Witkin
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-03-18

6.  Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy.

Authors:  Alessandra Ferraresi; Andrea Esposito; Carlo Girone; Letizia Vallino; Amreen Salwa; Ian Ghezzi; Suyanee Thongchot; Chiara Vidoni; Danny N Dhanasekaran; Ciro Isidoro
Journal:  Cells       Date:  2021-11-17       Impact factor: 6.600

7.  Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy.

Authors:  M Jiang; S Fernandez; W G Jerome; Y He; X Yu; H Cai; B Boone; Y Yi; M A Magnuson; P Roy-Burman; R J Matusik; S B Shappell; S W Hayward
Journal:  Cell Death Differ       Date:  2009-10-16       Impact factor: 15.828

8.  Lysophosphatidic Acid Is Associated With Cardiac Dysfunction and Hypertrophy by Suppressing Autophagy via the LPA3/AKT/mTOR Pathway.

Authors:  Jinjing Yang; Jiyao Xu; Xuebin Han; Hao Wang; Yuean Zhang; Jin Dong; Yongzhi Deng; Jingping Wang
Journal:  Front Physiol       Date:  2018-09-18       Impact factor: 4.566

9.  Lysophosphatidic acid receptor LPA3 prevents oxidative stress and cellular senescence in Hutchinson-Gilford progeria syndrome.

Authors:  Wei-Min Chen; Jui-Chung Chiang; Yueh-Chien Lin; Yu-Nung Lin; Pei-Yun Chuang; Ya-Chi Chang; Chien-Chin Chen; Kao-Yi Wu; Jung-Chien Hsieh; Shih-Kuo Chen; Wei-Pang Huang; Benjamin P C Chen; Hsinyu Lee
Journal:  Aging Cell       Date:  2019-11-12       Impact factor: 9.304

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.